247 related articles for article (PubMed ID: 35386712)
21. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
[TBL] [Abstract][Full Text] [Related]
22. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
23. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.
Wang W; Ye C; Liu J; Zhang D; Kimata JT; Zhou P
PLoS One; 2014; 9(12):e115987. PubMed ID: 25541967
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
25. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
26. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
[TBL] [Abstract][Full Text] [Related]
27. CRISPR/Cas9-mediated homology-directed repair by ssODNs in zebrafish induces complex mutational patterns resulting from genomic integration of repair-template fragments.
Boel A; De Saffel H; Steyaert W; Callewaert B; De Paepe A; Coucke PJ; Willaert A
Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30355591
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
[TBL] [Abstract][Full Text] [Related]
31. Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos.
Schmidt JK; Strelchenko N; Park MA; Kim YH; Mean KD; Schotzko ML; Kang HJ; Golos TG; Slukvin II
Sci Rep; 2020 Oct; 10(1):18457. PubMed ID: 33116147
[TBL] [Abstract][Full Text] [Related]
32. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
33. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection.
Ye L; Wang J; Beyer AI; Teque F; Cradick TJ; Qi Z; Chang JC; Bao G; Muench MO; Yu J; Levy JA; Kan YW
Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9591-6. PubMed ID: 24927590
[TBL] [Abstract][Full Text] [Related]
34. Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.
Gorry PR; Zhang C; Wu S; Kunstman K; Trachtenberg E; Phair J; Wolinsky S; Gabuzda D
Lancet; 2002 May; 359(9320):1832-4. PubMed ID: 12044382
[TBL] [Abstract][Full Text] [Related]
35. A Universal Surrogate Reporter for Efficient Enrichment of CRISPR/Cas9-Mediated Homology-Directed Repair in Mammalian Cells.
Yan N; Sun Y; Fang Y; Deng J; Mu L; Xu K; Mymryk JS; Zhang Z
Mol Ther Nucleic Acids; 2020 Mar; 19():775-789. PubMed ID: 31955009
[TBL] [Abstract][Full Text] [Related]
36. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
37. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
[TBL] [Abstract][Full Text] [Related]
38. Genome editing of CCR5 by AsCpf1 renders CD4
Liu Z; Liang J; Chen S; Wang K; Liu X; Liu B; Xia Y; Guo M; Zhang X; Sun G; Tian G
Cell Biosci; 2020; 10():85. PubMed ID: 32670545
[TBL] [Abstract][Full Text] [Related]
39. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.
Zhang JP; Li XL; Li GH; Chen W; Arakaki C; Botimer GD; Baylink D; Zhang L; Wen W; Fu YW; Xu J; Chun N; Yuan W; Cheng T; Zhang XB
Genome Biol; 2017 Feb; 18(1):35. PubMed ID: 28219395
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.
Romito M; Juillerat A; Kok YL; Hildenbeutel M; Rhiel M; Andrieux G; Geiger J; Rudolph C; Mussolino C; Duclert A; Metzner KJ; Duchateau P; Cathomen T; Cornu TI
Biotechnol J; 2021 Jan; 16(1):e2000023. PubMed ID: 33103367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
